Homeopathic Claims Pose Continuing FTC/FDA Regulatory Conflict

FTC shuts down the second marketer this year for making fraudulent claims for human chorionic gonadotropin weight-loss products. Enforcing against other homeopathics’ claims that violate advertising regulations, however, is on hold until FTC resolves its differences with FDA’s oversight of the category.

More from Archive

More from HBW Insight